SecSonar.com

Daré Bioscience, Inc. (DARE)

Daré Bioscience, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Daré Bioscience, Inc. (DARE) is a Biotechnology company based in US with a market capitalization of $21.6M. Revenue grew 10429.4% year-over-year and free cash flow was negative at -$10.3B. This page tracks DARE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 21 employees · IPO Apr 10, 2014

Valuation

Valuation & price

$2.17 · as of May 17, 2026 · -33.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

7.60

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.16$2.23$1.30Jul 25Dec 25Jul 26Jul 7, 25$2.40Jul 9, 25$2.44Jul 11, 25$2.52Jul 15, 25$2.84Jul 17, 25$2.50Jul 21, 25$2.68Jul 23, 25$2.66Jul 25, 25$2.57Jul 29, 25$2.48Jul 31, 25$2.40Aug 4, 25$2.39Aug 6, 25$2.26Aug 11, 25$1.97Aug 13, 25$2.11Aug 15, 25$2.20Aug 19, 25$2.02Aug 21, 25$2.10Aug 25, 25$2.08Aug 27, 25$2.02Aug 29, 25$2.02Sep 3, 25$2.06Sep 5, 25$2.15Sep 9, 25$2.16Sep 11, 25$2.11Sep 16, 25$2.10Sep 18, 25$2.08Sep 22, 25$2.04Sep 24, 25$2.14Sep 26, 25$2.09Sep 30, 25$2.10Oct 2, 25$2.15Oct 6, 25$2.25Oct 8, 25$2.29Oct 10, 25$2.12Oct 14, 25$2.06Oct 16, 25$2.12Oct 21, 25$2.13Oct 23, 25$2.09Oct 27, 25$2.03Oct 29, 25$2.02Oct 31, 25$1.96Nov 4, 25$1.81Nov 6, 25$1.81Nov 10, 25$1.82Nov 12, 25$1.98Nov 14, 25$1.86Nov 18, 25$1.78Nov 20, 25$1.63Nov 25, 25$1.77Nov 28, 25$1.84Dec 2, 25$1.72Dec 4, 25$1.79Dec 8, 25$1.84Dec 10, 25$1.99Dec 12, 25$2.47Dec 16, 25$2.26Dec 18, 25$2.28Dec 22, 25$2.16Dec 24, 25$2.17Dec 29, 25$2.00Jan 2, 26$1.95Jan 6, 26$1.96Jan 8, 26$2.07Jan 12, 26$1.94Jan 14, 26$2.03Jan 16, 26$1.93Jan 21, 26$1.94Jan 23, 26$1.95Jan 27, 26$1.97Jan 29, 26$1.90Feb 2, 26$1.76Feb 4, 26$1.77Feb 9, 26$1.71Feb 11, 26$1.72Feb 13, 26$1.70Feb 18, 26$1.65Feb 20, 26$1.65Feb 24, 26$1.66Feb 26, 26$1.67Mar 2, 26$1.61Mar 4, 26$1.56Mar 6, 26$1.53Mar 10, 26$1.49Mar 12, 26$1.48Mar 17, 26$1.45Mar 19, 26$1.30Mar 23, 26$1.37Mar 25, 26$1.40Mar 27, 26$1.55Mar 31, 26$1.82Apr 2, 26$1.74Apr 7, 26$1.77Apr 9, 26$1.85Apr 13, 26$1.78Apr 15, 26$1.79Apr 17, 26$2.95Apr 22, 26$2.27Apr 24, 26$2.11Apr 28, 26$2.19Apr 30, 26$2.28May 4, 26$3.11May 6, 26$3.16May 8, 26$2.75May 12, 26$2.63May 14, 26$2.86May 18, 26$2.11May 20, 26$2.33May 22, 26$2.37May 28, 26$2.28Jun 1, 26$2.19Jun 3, 26$2.05Jun 5, 26$1.88Jun 9, 26$1.92Jun 11, 26$2.03Jun 15, 26$1.98Jun 17, 26$2.08Jun 22, 26$2.05Jun 24, 26$2.08Jun 26, 26$2.09Jul 2, 26$2.07
$1.3052-week range$3.27
Loading valuation history…

Fundamentals

Key fundamentals

$21.6M

Market cap

10429.4%

Revenue growth (YoY)

-137.6%

Gross margin

-$10.3B

Free cash flow (USD)

-$22.1M

Net debt

Net cash position

1215.6%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$766.0KFY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$10.0MFY 2023$2.8MFY 2024$9.8KFY 2025$1.0M
$766K$1M

Free cash flow by year

2016 → 2025

FY 2016$-34.1MFY 2017$-2.5MFY 2018$-10.3MFY 2019$-13.3MFY 2020$-25.3MFY 2021$-28.8MFY 2022$-18.2MFY 2023$-39.5MFY 2024$4.8MFY 2025$-10.3B
-$34.1M-$10.3B

Gross margin by year

2022 → 2025

FY 2022-201.4%FY 2023-670.6%FY 2024-146110.2%FY 2025-137.6%
-201.4%-137.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCorporate Presentation ReleasedJun 22, 2026Filing
  • 8-K eventStockholder Meeting ResultsJun 12, 2026Filing
  • 8-K eventEquity Offering CompletedMay 18, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventEquity Offering CompletedMay 7, 2026Filing
  • 8-K eventCorporate Presentation UpdateApr 22, 2026Filing
  • 8-K eventEquity Offering CompletedApr 20, 2026Filing
  • 8-K eventDirector ReclassificationApr 17, 2026Filing
  • 8-K eventEquity Offering CompletedApr 13, 2026Filing

Questions

Frequently asked questions

What is Daré Bioscience, Inc.'s market cap?

Daré Bioscience, Inc. (DARE) has a market capitalization of $21.6M.

What is DARE's P/E ratio?

A meaningful P/E ratio is not available for DARE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is DARE's price-to-book (P/B) ratio?

DARE trades at 7.60 times book value per share.

Are insiders buying DARE stock?

SEC Form 4 filings show no open-market insider buys at Daré Bioscience, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

HOWL

Werewolf Therapeutics, Inc.

$21.9M

VTGN

VistaGen Therapeutics, Inc.

$20.9M

KZIA

Kazia Therapeutics Limited

$20.8M

PLUR

Pluri Inc.

$20.7M

ABVC

ABVC BioPharma, Inc.

$20.3M

XCUR

Exicure, Inc.

$20.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.